Transcripts available in:

About this episode

The COVID-19 pandemic has brought a new global awareness of the accessibility of diagnostics: we need to test to protect with equal access for all. In this episode of Global Health Matters, we answer key questions such as “how available are essential diagnostics in low- and middle-income countries (LMICs)?”

Host Garry Aslanyan interviews our special guests who have a deep understanding of diagnostics and their application worldwide. Bill Rodriguez is CEO of FIND, the global alliance for diagnostics, and is also founder of his own diagnostics company, Daktari Diagnostics. Our second guest is Sikhulile Moyo who led the team that helped discover the Omicron variant in Botswana through careful cross-examination of COVID-19 tests.

Join us in this podcast episode to understand the state of diagnostic testing in LMICs and how to achieve equity in access to testing in all countries.

Listen on

Apple Podcasts ¦ Spotify ¦ Google Podcasts ¦ Amazon Music ¦ Stitcher

Listen on YouTube

14 June 2022

Test to protect: equal access to diagnostics for all

Learn more

Availability of essential diagnostics in ten low-income and middle-income countries (The Lancet Global Health)

The Lancet Commission on diagnostics: transforming access to diagnostics (The Lancet)

Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa (Nature)

Biographies of our host and guests

You may also be interested in these previous episodes

The CC BY-NC-SA 3.0 IGO creative commons license allows users to freely copy, reproduce, reprint, distribute, translate and adapt the work for non-commercial purposes, provided TDR is acknowledged as the source and adapted material is issued under the same licensing terms using the following suggested citation: Global Health Matters. Geneva: TDR; 2021. License: CC BY-NC-SA 3.0 IGO.